Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing
litigation
NewsletterReceive the most important news of the day by email
Sandoz has agreed to pay another group of plaintiffs in the long-running
price-fixing litigation it inherited from former parent company...
11 hours ago
from: FiercePharma
- Sandoz settles US antitrust case for $275m Sandoz (SIX:SDZ), a division of Novartis (SIX:NOVN), has reached a $275
million settlement agreement with the end payer plaintiffs in a US...
from: Investing.com
- Sandoz: measures to resolve US antitrust dispute Sandoz today announced a series of steps aimed at resolving the U.S.
generic antitrust class action litigation. Sandoz has reached a...
from: marketscreener.com